ICAD Platform — Decide

AI-Enabled Decisions — Where Intelligence Becomes Action

Agentic services orchestrate tasks, route exceptions, and enforce configurable oversight. Intelligent orchestration coordinates experiments, instruments, and decisions across the governed context graph. You configure the autonomy level — from human-supervised to fully autonomous.

The Reality Check

Everyone Wants AI. Almost No One Is Ready.

The gap between AI ambition and AI readiness in pharma R&D is immense. Without governed data, scientific context, and traceable lineage, AI produces hallucinations — not decisions. Read the five-question framework for evaluating AI readiness →

0%
Expect AI adoption within 2 years

77% of pharma organizations expect significant AI adoption within two years — but ambition does not equal readiness (Pistoia Alliance, AI in Life Sciences Survey, 2024).

0%
Rank AI as top investment priority

63% of life sciences leaders rank AI as their top investment area — but lack the infrastructure to act on it (Pistoia Alliance, 2025).

0%
Track lab ROI with quantitative metrics

Only 37% of pharma organizations track lab investment ROI with quantitative metrics — making it nearly impossible to measure AI impact on operations (Pistoia Alliance, 2025).

Three Horizons

Honest About Where We Are — Clear About Where We're Going

Decide is the most forward-looking — and the most dependent on foundation principles. Here is where each capability stands: what is in development, what is next, and what is on the roadmap. Start at Integrate, compound toward Decide.

Now — In Development

AI-Assisted Acceleration

  • AI-assisted factory acceleration — converter and adapter drafts, metadata extraction, and validation assets generated for engineer review
  • Closed-loop lab automation reference architecture with GxP-compliant approval gates
In Development
Next — 2026+

Agentic Orchestration

  • Agentic workflow orchestration — configurable oversight from supervised to fully autonomous
  • Exception triage and routing — automated classification, priority scoring, and escalation
  • AI-assisted IND compilation and regulatory reporting with cross-program evidence synthesis
  • CMC data package assembly — automated comparability protocols and method transfer documentation
Planned
Future — 2027+

Predictive Intelligence

  • Predictive decision support — stability trending, shelf-life prediction, risk scoring, and portfolio optimization
  • Process digital twins — simulation models for process parameters, conditions optimization, and experiment reduction
  • Self-driving lab operations with configurable autonomy and continuous learning
  • Autonomous regulatory analysis and proactive compliance monitoring
  • Cross-portfolio AI pattern detection — surfacing signals across programs and sites
On Roadmap
The ZONTAL Approach

Configurable Autonomy — You Set the Level

ZONTAL supports the full spectrum — from supervised workflows with human approval gates for regulated decisions to fully autonomous execution for routine operations. Approval gates and change control are embedded in the pipeline. You configure the oversight level per workflow.

1

AI Proposes

Agentic services analyze the governed context graph and propose actions, reports, or workflows.

AI Agent
2

Automation Executes

Orchestration engines and workcell automation carry out approved tasks with full audit trail.

Automation
3

Exceptions Route

Deviations and edge cases are flagged and routed to qualified reviewers with full context.

AI Triage
4

Configurable Oversight

Regulated decisions route to qualified reviewers. Routine operations execute autonomously. You configure which workflows need human oversight.

Your Rules

Base Models Will Commoditize

GPT, Claude, Gemini, and open-source LLMs are converging. Foundation model capabilities are a commodity input. Every competitor can access the same base models. The differentiator is the data they operate on.

Proprietary Data Won't

Your wet-lab data — stability studies, method transfers, batch genealogies, process parameters — is irreplaceable. ZONTAL's infrastructure turns proprietary data into a compounding strategic moat that no model provider can replicate.

Market Validation

What the Market Confirms

The configurable autonomy model is validated by leading research, pharma AI deployments, and the trajectory of lab automation partners — not just our opinion.

"Human skills remain essential. The leading pharma examples are closed-loop systems where AI proposes, automation executes, and scientists supervise exceptions and strategy."
Nature, February 2026
"Out of 202 Complete Response Letters, 150 involved quality and manufacturing issues — 74% of FDA rejections trace back to the data and process infrastructure that AI-enabled decisions must govern."
Pharma Manufacturing, 2025
"Proprietary data is the moat. Base models will commoditize. Durable advantage comes from the quality, breadth, and accessibility of proprietary wet-lab data — not from the AI model itself."
Deloitte — Life Sciences AI Strategy
Watch

AI-Enabled Decisions — Built on Governed Data

See how the Decide layer turns governed scientific context into trusted, auditable decisions.

Your ZONTAL Journey

Decide establishes the AUTONOMOUS stage — the culmination of governed integration, scientific context, and cross-program intelligence. AI-enabled decisions built on a foundation that makes them trustworthy.

1

Connected

Instruments integrated, data flowing, metadata enriched

2

Contextual

Scientific context graph, governed lineage, reconciled identifiers

3

Intelligent

Accelerated investigations and tech transfer

4

Autonomous

Stability intelligence, agentic workflows, supervised automation

Each Principle Compounds on the One Before

AI-enabled decisions require scientific intelligence, governed context, and industrialized integration. Without the foundation, AI produces noise, not insight. Start at Integrate, compound toward Decide.

“Imagine method development via AI/ML… generate it into Allotrope and send it directly to labs. That would be a dream come true.”

Azzedine Dabo, Principal Scientist, GSK

Ready to Build Your Data Moat?

Base models commoditize. Your proprietary wet-lab data won't. Turn governed scientific context into AI-enabled decisions — with configurable autonomy levels from supervised to fully autonomous.